Hs. Yin et Yj. Lee, HETEROGENEITY AND DIFFERENTIAL EXPRESSION OF THE GAMMA-AMINOBUTYRIC ACID(A) (GABA(A)) BENZODIAZEPINE RECEPTOR IN THE AVIAN BRAIN DURING DEVELOPMENT/, Cellular and molecular neurobiology, 14(4), 1994, pp. 359-371
1. The changes in the GABA,/benzodiazepine receptor in chicken brain d
uring development has been studied by using H-3-flunitrazepam as the p
robe for the benzodiazepine modulator site and the antibodies recogniz
ing the receptor protein, In the telencephalon and optic tectum, the p
roteins of 48, 50, and 51 kD were markedly labeled by H-3-flunitrazepa
m from embryonic day 18 to postnatal days, as revealed by photoaffinit
y labeling and SDS-PAGE of the brain membranes; the 51-kD protein appe
ared to be the predominant one in labeling intensity except at embryon
ic day 18 and postnatal days 14 and 28, whereas the 47- and 50-kD prot
eins were dominant in the cerebellum, However, the 47- and 48-kD prote
ins were faintly seen after postnatal day 28 in the three regions exam
ined. 2. Immunoblotting using a monoclonal antibody against the 50- an
d 51-kD proteins showed that the straining pattern ill the developing
telecephalon or optic tectum was similar to the 50 kD/51 kD pattern ob
tained from fluorography. The antibody also stained the 50- and 51-kD
proteins in the cerebellum despite the fact that the 51-kD protein was
barely seen in the fluorogram. Moreover, the 50-kD protein was recogn
ized by an antiserum raised against a partial sequence of the alpha 1
subunit of the receptor expressed in bacteria. The staining levels for
the 50-kd protein by the antiserum on immunoblots of the brain region
s were low in embryonic animals but higher during postnatal stages, co
nsistent with that seen in fluorograms. 3. Receptor binding autoradiog
raphy using H-3-flunitrazepam exhibited that varying degrees of labeli
ng intensity occurred among various brain areas at different ages. Hig
h densities of binding were present in the olfactory bulb, paleostriat
um, optic tectum, and midbrain. These results support the diversity of
the GABA(A)/benzodiazepine receptor in the vertebrate CNS.